Inclusion of pregnant women in COVID-19 vaccine development

The virus subsequently spread rapidly throughout China and other countries worldwide, and on March 11, 2020, the outbreak was declared a pandemic. Since March 11, 2020, the virus has continued to spread, causing substantial morbidity and mortality in many countries. A systematic review and meta-anal...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet infectious diseases 2020-09, Vol.20 (9), p.1007-1008
Hauptverfasser:	Heath, Paul T, Le Doare, Kirsty, Khalil, Asma
Format:	Artikel
Sprache:	eng
Schlagworte:	Betacoronavirus - immunology Clinical trials Comment Congenital anomalies Congenital defects Coronavirus Infections - immunology Coronavirus Infections - prevention & control Coronavirus Infections - virology Coronaviruses COVID-19 COVID-19 Vaccines Female Fetuses Humans Immune response Immunization Income Infants Infectious diseases Morbidity Pandemics Pandemics - prevention & control Pneumonia, Viral - prevention & control Pneumonia, Viral - virology Pregnancy Pregnant Women Premature birth SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Vaccination Vaccine development Vaccines Viral diseases Viral Vaccines - immunology Viruses Womens health
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The virus subsequently spread rapidly throughout China and other countries worldwide, and on March 11, 2020, the outbreak was declared a pandemic. Since March 11, 2020, the virus has continued to spread, causing substantial morbidity and mortality in many countries. A systematic review and meta-analysis of mainly small case series reported that a high proportion of women with confirmed COVID-19 infection had preterm birth (
ISSN:	1473-3099 1474-4457
DOI:	10.1016/S1473-3099(20)30638-1